The goal of this study, which incorporated clinic visits, blood sampling, and diagnostic imaging, was to compare the sensitivity and specificity of the BCAT1/IKZF1 blood test to CEA, when applied on a single occasion, for detection of recurrent CRC in patients undergoing surveillance. This evidence concerns the gene CEACAM5 and colorectal carcinoma.